US FDA approves Moderna's next-gen COVID vaccine for adults 65 or older

Moderna's updated COVID-19 vaccine has received FDA approval for individuals aged 65 and older, marking the first endorsement under stricter regulatory guidelines. The vaccine is also authorized for those between 12 and 64 who have underlying health conditions that increase their risk. This approval signifies a step forward in protecting vulnerable populations against COVID-19.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/9yvQmZ5
via IFTTT